文献速递白血病MDS 与骨髓增殖性肿瘤

TET功能不足状态下进展为髓系白血病的分子发病机制

Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status.
PubMed 文献 · Blood Adv · 2020-01-01

该研究通过构建Tet2/Tet3不同缺陷程度的小鼠模型,探讨TET功能逐步下降对AML发生的影响。结果显示,Tet2与Tet3双缺陷小鼠均快速发生侵袭性AML(中位生存10.7周),而单基因缺陷小鼠AML潜伏期更长(中位生存约27周)。所有发生AML的T2ΔT3和ΔT2T3小鼠均出现剩余未靶向Tet2或Tet3等位基因的失活,提示残余Tet等位基因的自发失活是TET功能不足状态下AML发生的反复遗传事件。

要点

  • Tet2/Tet3双缺陷小鼠全部发生侵袭性AML,中位生存10.7周。
  • 单基因缺陷小鼠AML潜伏期更长,中位生存约27周。
  • 发生AML的小鼠均出现剩余Tet2或Tet3等位基因的自发失活。

核心结论

  • 残余Tet2或Tet3等位基因的自发失活是TET功能不足状态下AML发生的反复遗传事件。

研究设计与样本

  • 研究通过将Tet2f/f和Tet3f/f小鼠与表达Mx1-Cre的小鼠杂交,构建Tet2f/wtTet3f/fMx-Cre+(T2ΔT3)、Tet2f/fTet3f/wtMx-Cre+(ΔT2T3)和Tet2f/fTet3f/fMx-Cre+(ΔT2ΔT3)小鼠模型。

主要发现

  • 所有ΔT2ΔT3小鼠均死于侵袭性AML,中位生存期为10.7周。
  • T2ΔT3和ΔT2T3小鼠发生AML的潜伏期更长,中位生存期约27周。
  • 所有9只发生AML的T2ΔT3小鼠和8只发生AML的ΔT2T3小鼠均分别显示剩余未靶向的Tet2或Tet3等位基因失活,原因包括基因外显子丢失或Tet3的终止获得突变。
  • 全外显子组测序未在任何小鼠中检测到除Tet3以外的反复突变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Loss-of-function mutations in ten-eleven translocation-2 (TET2) are recurrent events in acute myeloid leukemia (AML) as well as in preleukemic hematopoietic stem cells (HSCs) of age-related clonal hematopoiesis. TET3 mutations are infrequent in AML, but the level of TET3 expression in HSCs has been found to decline with age. We examined the impact of gradual decrease of TET function in AML development by generating mice with Tet deficiency at various degrees. Tet2f/f and Tet3f/f mice were crossed with mice expressing Mx1-Cre to generate Tet2f/wtTet3f/fMx-Cre+ (T2ΔT3), Tet2f/fTet3f/wtMx-Cre+ (ΔT2T3), and Tet2f/fTet3f/fMx-Cre+ (ΔT2ΔT3) mice. All ΔT2ΔT3 mice died of aggressive AML at a median survival of 10.7 weeks. By comparison, T2ΔT3 and ΔT2T3 mice developed AML at longer latencies, with a median survival of ∼27 weeks. Remarkably, all 9 T2ΔT3 and 8 ΔT2T3 mice with AML showed inactivation of the remaining nontargeted Tet2 or Tet3 allele, respectively, owing to exonic loss in either gene or stop-gain mutations in Tet3. Recurrent mutations other than Tet3 were not noted in any mice by whole-exome sequencing. Spontaneous inactivation of residual Tet2 or Tet3 alleles is a recurrent genetic event during the development of AML with Tet insufficiency.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Shrestha R, Sakata-Yanagimoto M, Maie K, et al. Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status. Blood Adv. 2020. PMID: 32126143. doi:10.1182/bloodadvances.2019001324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。